Filing Details
- Accession Number:
- 0000874015-20-000170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-09 20:14:17
- Reporting Period:
- 2020-12-07
- Accepted Time:
- 2020-12-09 20:14:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874015 | Ionis Pharmaceuticals Inc | IONS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
897667 | T Stanley Crooke | C/O Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad, CA 92010 | Exec Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-07 | 5,000 | $51.87 | 645,391 | No | 4 | S | Indirect | by trust |
Common Stock | Disposition | 2020-12-07 | 6,000 | $51.50 | 639,391 | No | 4 | S | Indirect | by trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | by trust |
No | 4 | S | Indirect | by trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,021 | Direct | |
Common Stock | 1,581 | Indirect | by wife |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 2, 2020.